Singapore: South Korea's Dong-A Pharmaceutical announced positive top-line results from its phase II clinical trial of D...
Singapore: US-based Ariad Pharmaceuticals has granted Specialised Therapeutics Australia (STA), a specialty pharmaceutic...
Singapore: Japan-based Eisai and Santen Pharmaceutical entered into an option agreement which grants Santen rights of ev...
Singapore: Takeda Development Center Shanghai (TDC Shanghai) and Takeda Development Center Asia has commenced TOURMALINE...
Singapore: China's Food and Drug Administration plans to remove its mandatory animal test requirements for domestically ...
Singapore: Japan-based global analytics technology provider, Shimadzu (Asia Pacific), has launched i-Series of new indus...
Singapore: China's HUYA Bioscience has struck a partnership with Changzhou Center for Biotech Development (CZCBD) to foc...
Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...
Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...
Singapore: The US Food and Drug Administration has formed an internal task force that will support the development of ne...
Singapore: In a bid to boost drug pipeline, Gilead Sciences has acquired Farnesoid X Receptor (FXR) program comprising s...
Singapore: Global bio pharmaceutical company, Merck Sharp and Dohme, has received USFDA nod to review the supplemental b...
Singapore: A Chinese biotech firm, Chipscreen Biosciencees has received the China FDA nod for its flagship drug Epidaza ...
Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...
Singapore: Nature Biotechnology has published a peer-reviewed paper co-authored by the Biotechnology Industry Organizati...
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...
Singapore: The US Food and Drug Administration (FDA) has approved Genentech's Perjeta for people with her2-positive met...
Singapore: Monash Institute of Pharmaceutical Sciences (MIPS) has been recognised for the Monash-GSK Australian Centre f...
